Literature DB >> 28115398

Proinflammatory Effects of Hypoglycemia in Humans With or Without Diabetes.

Jacqueline M Ratter1,2, Hanne M M Rooijackers3, Cees J Tack3, Anneke G M Hijmans3, Mihai G Netea3, Bastiaan E de Galan3, Rinke Stienstra3,2.   

Abstract

Severe hypoglycemic events have been associated with increased cardiovascular mortality in patients with diabetes, which may be explained by hypoglycemia-induced inflammation. We used ex vivo stimulations of peripheral blood mononuclear cells (PBMCs) and monocytes obtained during hyperinsulinemic-euglycemic (5.0 mmol/L)-hypoglycemic (2.6 mmol/L) clamps in 11 healthy participants, 10 patients with type 1 diabetes and normal awareness of hypoglycemia (NAH), and 10 patients with type 1 diabetes and impaired awareness (IAH) to test whether the composition and inflammatory function of immune cells adapt to a more proinflammatory state after hypoglycemia. Hypoglycemia increased leukocyte numbers in healthy control participants and patients with NAH but not in patients with IAH. Leukocytosis strongly correlated with the adrenaline response to hypoglycemia. Ex vivo, PBMCs and monocytes displayed a more robust cytokine response to microbial stimulation after hypoglycemia compared with euglycemia, although it was less pronounced in patients with IAH. Of note, hypoglycemia increased the expression of markers of demargination and inflammation in PBMCs. We conclude that hypoglycemia promotes mobilization of specific leukocyte subsets from the marginal pool and induces proinflammatory functional changes in immune cells. Inflammatory responses were less pronounced in IAH, indicating that counterregulatory hormone responses are key modulators of hypoglycemia-induced proinflammatory effects. Hypoglycemia-induced proinflammatory changes may promote a sustained inflammatory state.
© 2017 by the American Diabetes Association.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28115398     DOI: 10.2337/db16-1091

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  25 in total

1.  Hypoglycaemia induces recruitment of non-classical monocytes and cytotoxic lymphocyte subsets in type 1 diabetes.

Authors:  Jacqueline M Ratter; Hanne M M Rooijackers; Cor W M Jacobs; Bastiaan E de Galan; Cees J Tack; Rinke Stienstra
Journal:  Diabetologia       Date:  2018-07-07       Impact factor: 10.122

Review 2.  Interdisciplinary approach to compensation of hypoglycemia in diabetic patients with chronic heart failure.

Authors:  Yana Anfinogenova; Elena V Grakova; Maria Shvedova; Kristina V Kopieva; Alexander T Teplyakov; Sergey V Popov
Journal:  Heart Fail Rev       Date:  2018-05       Impact factor: 4.214

Review 3.  The early detection of atherosclerosis in type 1 diabetes: why, how and what to do about it.

Authors:  Alicia Jenkins; Andrzej Januszewski; David O'Neal
Journal:  Cardiovasc Endocrinol Metab       Date:  2019-02-13

4.  Predictive model and risk engine web application for surgical site infection risk in perioperative patients with type 2 diabetes.

Authors:  Masaya Koshizaka; Ryoichi Ishibashi; Yukari Maeda; Takahiro Ishikawa; Yoshiro Maezawa; Minoru Takemoto; Koutaro Yokote
Journal:  Diabetol Int       Date:  2022-05-19

5.  Mathematical modeling of energy consumption in the acute inflammatory response.

Authors:  Ivan Ramirez-Zuniga; Jonathan E Rubin; David Swigon; Gilles Clermont
Journal:  J Theor Biol       Date:  2018-08-25       Impact factor: 2.691

6.  Impact of CD14++CD16+ monocytes on plaque vulnerability in diabetic and non-diabetic patients with asymptomatic coronary artery disease: a cross-sectional study.

Authors:  Naofumi Yoshida; Hiroyuki Yamamoto; Toshiro Shinke; Hiromasa Otake; Masaru Kuroda; Daisuke Terashita; Hachidai Takahashi; Kazuhiko Sakaguchi; Yushi Hirota; Takuo Emoto; Hilman Zulkifli Amin; Taiji Mizoguchi; Tomohiro Hayashi; Naoto Sasaki; Tomoya Yamashita; Wataru Ogawa; Ken-Ichi Hirata
Journal:  Cardiovasc Diabetol       Date:  2017-08-08       Impact factor: 9.951

7.  Aquaporin-4 deletion ameliorates hypoglycemia-induced BBB permeability by inhibiting inflammatory responses.

Authors:  Fei Zhao; Jiangshan Deng; Xiaofeng Xu; Fengya Cao; Kaili Lu; Dawei Li; Xiaojuan Cheng; Xiuzhe Wang; Yuwu Zhao
Journal:  J Neuroinflammation       Date:  2018-05-24       Impact factor: 8.322

Review 8.  A Bittersweet Response to Infection in Diabetes; Targeting Neutrophils to Modify Inflammation and Improve Host Immunity.

Authors:  Rebecca Dowey; Ahmed Iqbal; Simon R Heller; Ian Sabroe; Lynne R Prince
Journal:  Front Immunol       Date:  2021-06-03       Impact factor: 7.561

9.  Modification of the Association Between Severe Hypoglycemia and Ischemic Heart Disease by Surrogates of Vascular Damage Severity in Type 1 Diabetes During ∼30 Years of Follow-up in the DCCT/EDIC Study.

Authors:  Elke R Fahrmann; Laura Adkins; Henry K Driscoll
Journal:  Diabetes Care       Date:  2021-07-07       Impact factor: 17.152

Review 10.  Pathogen manipulation of host metabolism: A common strategy for immune evasion.

Authors:  Zachary Freyberg; Eric T Harvill
Journal:  PLoS Pathog       Date:  2017-12-07       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.